SCS Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.7M Sell
170,662
-415
-0.2% -$135K 0.62% 25
2025
Q1
$46.2M Buy
+171,077
New +$46.2M 0.59% 28